Ds Healthcare Group (DSKX) Gross Profit Margin starting from the second quarter 2017 to second quarter 2016, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ds Healthcare Group, Inc.  (DSKX)


Ds Healthcare Group's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DSKX Gross Profit Margin (Jun 30 2017)
Q2 		(Mar 31 2017)
Q1 		(Dec 31 2016)
Q4 		(Sep 30 2016)
Q3 		(Jun 30 2016)
Q2
Y / Y Revenue Change -53.97 %
Seq. Revenue Change 6.48 %
Revenue In Millions $2.23
Gross Profit Margin 58.96 %
Gross Profit Margin Total Ranking # 1501
Gross Profit In Millions $1.31
Y / Y Gross Profit Change -13.08 %
Seq. Gross Profit Change 27.52 %


Commenting Second Quarter 2017 Gross Profit Margin
Ds Healthcare Group, Inc. Gross Profit grew by 27.52 % in Q2 sequentially to 1 millions, while Revenue increased by 6.48 %, this led to improvement in the company's Gross Profit Margin to 58.96 %, above the Ds Healthcare Group, Inc. average Gross Profit Margin.


Observing second quarter 2017 results within Biotechnology & Pharmaceuticals industry 19 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1501, from total ranking in the previous quarter at 2071.
Learn about Gross Margin
DSKX's Gross Profit Margin second quarter 2017 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 20
Healthcare Sector # 197
Overall # 1346

Gross Profit Margin Statistics
High Average Low
79.85 % 50.51 % 7.17 %
(Sep 30 2016)  


DSKX Gross Income Trends • More of DSKX's Profitabilty Ratios • DSKX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
DSKX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DSKX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DSKX's Competitors
Gross Profit Margin Profit Margin for Ds Healthcare Group's Suppliers
Gross Profit Margin Profit Margin for DSKX's Customers

You may also want to know
DSKX's Annual Growth Rates DSKX's Profitability Ratios DSKX's Asset Turnover Ratio DSKX's Dividend Growth
DSKX's Roe DSKX's Valuation Ratios DSKX's Financial Strength Ratios DSKX's Gross Profit Growth
DSKX's Roa DSKX's Inventory Turnover Ratio DSKX's Growth Rates DSKX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2017, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Glucose Health, Inc.  99.20 %$ 0.034  Millions$ 0.034  Millions
Neurocrine Biosciences Inc   99.04 %$ 6.274  Millions$ 6.335  Millions
Lineage Cell Therapeutics Inc   98.69 %$ 0.376  Millions$ 0.381  Millions
Bluebird Bio Inc   97.49 %$ 16.296  Millions$ 16.716  Millions
Exelixis Inc   96.96 %$ 95.994  Millions$ 99.008  Millions
Seagen Inc   92.56 %$ 100.168  Millions$ 108.223  Millions
Biogen Inc   88.10 %$ 2,712.200  Millions$ 3,078.400  Millions
Gilead Sciences Inc   84.23 %$ 6,015.000  Millions$ 7,141.000  Millions
Cyclo Therapeutics Inc   84.06 %$ 0.440  Millions$ 0.523  Millions
Amgen Inc   82.38 %$ 4,786.000  Millions$ 5,810.000  Millions
Regenxbio Inc   79.93 %$ 5.245  Millions$ 6.562  Millions
Acorda Therapeutics Inc   78.73 %$ 109.773  Millions$ 139.438  Millions
Zeo Scientifix Inc   77.24 %$ 0.129  Millions$ 0.167  Millions
Halozyme Therapeutics Inc   76.92 %$ 25.962  Millions$ 33.750  Millions
Instil Bio Inc   76.74 %$ 0.874  Millions$ 1.139  Millions
Bio techne Corp  70.77 %$ 110.806  Millions$ 156.578  Millions
Vivosim Labs Inc   69.60 %$ 0.689  Millions$ 0.990  Millions
China Biologic Products Holdings Inc   66.27 %$ 59.168  Millions$ 89.278  Millions
Xtant Medical Holdings Inc   63.19 %$ 13.528  Millions$ 21.408  Millions
Ds Healthcare Group, Inc.  58.96 %$ 1.315  Millions$ 2.230  Millions
Repligen Corp  57.06 %$ 18.518  Millions$ 32.455  Millions
Vericel Corporation  54.76 %$ 9.283  Millions$ 16.953  Millions
Fresh Tracks Therapeutics Inc   53.17 %$ 1.819  Millions$ 3.421  Millions
Champions Oncology Inc   47.51 %$ 2.391  Millions$ 5.033  Millions
Enzo Biochem Inc  43.97 %$ 12.386  Millions$ 28.171  Millions
Cellular Biomedicine Group Inc   39.45 %$ 0.025  Millions$ 0.063  Millions
Nanostring Technologies Inc   29.16 %$ 10.086  Millions$ 34.592  Millions
Protalix Biotherapeutics inc   13.13 %$ 0.835  Millions$ 6.358  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.